Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis

NCT: NCT07820917 · NOT_YET_RECRUITING

NCT IDNCT07820917
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2029-09
SponsorUniversity of Michigan (OTHER)
First posted
Last updated

Brief Summary

This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.

Frequently Asked Questions

What is Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis?

Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis is a clinical trial registered under NCT07820917. Current status: NOT_YET_RECRUITING.

What is the status of NCT07820917?

The current status of NCT07820917 (Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis) is: NOT_YET_RECRUITING.

When did Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis start?

Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑